Can't argue too much with all that information. Nice DD! The only thing I can say is the pps doesn't support all that and that is the most important thing. All investors want a ROI and we are not getting that as of today. Hopefully with what you posted it will evenually show up in the pps which is what we all want to see!!
Nice compilation. But two points you don't mention. Potential Annual Revenues and Valuations are worthless as long as you have NOTHING finished, no product. Comparing BMSN with companies on the Nasdaq which have real products and revenues is like comparing apples with horse droppings. Even if it's only for valuation purposes.
BTW How do you know that we are so close to FDA approval? Or is it pure assumption and wishful thinking? Instead of approval it looks like more questions and further delays imo.